Identification

Symbol
OCTO
ISIN code
NL0000345718
Exchange / Market
Euronext
Handelssted
Amsterdam
Products family
Stocks
Market organization
EuronextAmsterdam
ICB
Biotechnology
Activity description

OctoPlus is a drug delivery company specialized in the development of improved pharmaceutical products that are based on OctoPlus' proprietary drug delivery technologies and have fewer side effects, improved patient convenience and a better efficacy/safety balance than existing therapies. In addition, the group is a leading European provider of advanced drug formulation and clinical scale manufacturing services to the pharmaceutical and biotechnology industries, with a focus on difficult-to-formulate active pharmaceutical ingredients.

  • Net sales break down by source of income as follows: sales of services (97.9%), licensing revenues (1.9%) and subsidies (0.2%).
  • Net sales are distributed geographically as follows: Europe (28.6%), North America (60.6%) and other (10.8%).
Website address
www.octoplus.nl
Issuer website
www.octoplus.nl

Operation

IPO date
man 08/03/2010
IPO type
Initial Public offering
New Issue Special Session
Catégorie
New Issue Special Session
Operation procedure

OFFER SHARES

Operation description

Admission to listing and trading of 211,806 newly issued ordinary shares which form part of a private placement of 3,232,106 newly issued ordinary shares.

Operation calendar

Octoplus NV has applied for admission of the remaining 211,806 Shares issued pursuant to the Private Placement to listing and trading on Euronext Amsterdam and expect that trading in these Shares on Euronext Amsterdam will commence on or about 8 March 2010(the “Listing Date”).